Cabot (NYSE:CBT) Downgraded to “Hold” at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft downgraded shares of Cabot (NYSE:CBT) from a buy rating to a hold rating in a research report report published on Thursday morning, MarketBeat Ratings reports. They currently have $95.00 target price on the specialty chemicals company’s stock, up from their previous target price of $88.00.

Other equities analysts have also recently issued research reports about the company. StockNews.com cut Cabot from a strong-buy rating to a buy rating in a report on Wednesday, February 14th. Mizuho began coverage on Cabot in a research note on Wednesday, March 27th. They set a buy rating and a $104.00 target price for the company. Finally, UBS Group cut shares of Cabot from a buy rating to a neutral rating and dropped their price target for the company from $90.00 to $87.00 in a research note on Monday, January 8th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Cabot presently has a consensus rating of Moderate Buy and an average target price of $90.17.

Cabot Stock Performance

Shares of NYSE CBT opened at $92.01 on Thursday. The stock has a market cap of $5.10 billion, a price-to-earnings ratio of 11.95, a PEG ratio of 0.97 and a beta of 1.28. Cabot has a 12 month low of $63.73 and a 12 month high of $98.34. The company has a 50 day simple moving average of $88.31 and a two-hundred day simple moving average of $79.82. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74.

Cabot (NYSE:CBT) last posted its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.07. The firm had revenue of $958.00 million during the quarter, compared to analysts’ expectations of $927.28 million. Cabot had a net margin of 11.24% and a return on equity of 25.52%. As a group, analysts predict that Cabot will post 6.58 earnings per share for the current year.

Insider Activity at Cabot

In related news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the transaction, the executive vice president now directly owns 97,201 shares in the company, valued at $7,767,331.91. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.07% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cabot

A number of institutional investors have recently added to or reduced their stakes in CBT. EverSource Wealth Advisors LLC increased its stake in shares of Cabot by 143.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 196 shares during the last quarter. Parkside Financial Bank & Trust increased its position in Cabot by 176.0% during the first quarter. Parkside Financial Bank & Trust now owns 414 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 264 shares during the last quarter. Arlington Trust Co LLC purchased a new position in Cabot during the fourth quarter worth about $34,000. Hexagon Capital Partners LLC boosted its holdings in Cabot by 81.8% in the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 207 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its stake in shares of Cabot by 372.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 398 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.